Introduction {#sec1_1}
============

Spasm of accommodation causes pseudo-myopia without any accommodative effort, which was first described by von Graefe in 1856 \[[@B1]\]. This condition is a clinical diagnosis characterized by fluctuating refraction status and may be a presentation of a nonorganic visual disorder \[[@B1], [@B2]\]. There are reports of neurological lesions causing accommodative spasm \[[@B3], [@B4]\].

In this report, we describe a patient who presented with excessive accommodation and subsequent sudden loss of vision without any organic deficit. She recovered after both psychotherapy and a course of atropine eye drops.

Case Report {#sec1_2}
===========

A 10-year-old girl was admitted to the hospital due to painless vision loss in both eyes without a history of ocular or systemic diseases. Five months prior to presentation, she had been diagnosed with myopia and was prescribed spectacles based on manifest but not cycloplegic refraction (right eye: −6.50 D; left eye −6.25 D) (Fig. [1](#F1){ref-type="fig"}).

At the first visit, her best-corrected visual acuity (BCVA) with her current glasses was 20/100 in the right eye and 20/80 in the left. Noncycloplegic auto-refraction measurements were −8.50/--0.50 × 057 D in the right eye and −9.25/--0.50 × 153 D in the left. She presented with full-eye movement, normal pupils with no APD, and normal anterior and posterior segment exams. She was prescribed 0.5% atropine in both eyes once daily; 5 days later, cycloplegic retinoscopy and auto-refraction findings were +0.75/--0.50 × 007 D in the right eye and +0.75/--0.50 × 047 D in the left. She reverted to an apparent myopic refraction with poor distance visual acuity when atropine was withdrawn over the next 3 weeks. She was diagnosed with bilateral accommodative spasm and again prescribed 0.5% atropine once daily with +3.00 D spectacles for near work. Over the next 2 weeks, her vision did not improve, but her cycloplegic refraction stabilized. Atropine dosage was lowered to 0.1% atropine once daily to minimize side effects. The patient then reported new visual loss 2 days after starting 0.1% atropine with BCVA of light perception in the right eye and hand motion at 0.2 m in the left.

On examination, no new abnormalities were found. MRIs of the brain and orbits with and without contrast were also unremarkable. She continued to conduct her daily activities, including schoolwork, without difficulty; at school, she was noticed to easily lose her temper and was prone to be talkative with attention-seeking behaviors. At our clinic, her visual response to surrounding stimuli was normal. Hence, we referred her to a pediatric psychiatrist with a clinical suspicion of functional visual loss. She was diagnosed with conversion disorder and underwent psychological therapy. Our final diagnosis was functional visual loss associated with spasm of accommodation.

Four weeks later (10 weeks after presentation to ophthalmology), her manifest refraction regressed to high myopia with low visual acuity; thus, she was restarted on atropine in conjunction with her psychotherapy. We tried different concentrations including 0.5% once daily (8 weeks) in addition to reading glasses, then 0.1% once daily (4 weeks) with the aim of reducing the side effects of topical atropine. During this course, the refraction gradually stabilized although reported acuity remained poor. Surprisingly, 6 months after presentation, her BCVA improved to 20/20 in both eyes. We continued treatment with 0.01% atropine eye drops once daily, and no fluctuation of the refraction or BCVA were noted. On follow-up, her atropine drops were discontinued and visual acuity remained normal.

Discussion {#sec1_3}
==========

Spasm of accommodation has been described as a presentation of functional vision loss in children with mental illness \[[@B1]\]. Studies have reported that the prevalence of nonorganic visual loss in children was approximately 50% at a routine ophthalmological examination \[[@B5]\] and its annual incidence was roughly 3.5% \[[@B6]\]. Even though the visual disorder of this patient was significant, we thought more about a psychogenic component since our clinical examination and imaging studies did not reveal any ophthalmic cause for her problem. Ophthalmologists should always remain suspicious of nonorganic visual loss in cases where there is an inconsistency between symptoms and findings.

In this case, psychotherapy alone was not enough to control pseudo-myopia and restore normal visual function, so we titrated different concentrations of atropine in combination. A recent study has revealed that 0.05, 0.025, and 0.01% atropine could prevent the progression of myopia \[[@B7]\]; nevertheless, there has not been any guideline for atropine concentration for accommodative spasm. Laria et al. \[[@B8]\] prescribed 1% atropine once a day and spectacle of +1.0 in both eyes to control the accommodation of their patient with near reflex spasm. Shanker and Nigam \[[@B9]\] administered 1% atropine twice a day for 1 week with punctual occlusion to relax the accommodation of a patient with the spasm of near reflex. However, Wakayama et al. \[[@B10]\] reported a higher incidence of adverse effect with 1% atropine compared to 0.5 and 0.25%. Hence, we decreased the concentration due to the prolonged use of atropine in our patient. Fortunately, she recovered with combined pharmacologic and psychologic treatment.

This case represents the first report of the management of functional visual loss in a patient with accommodative spasm in Vietnam. The sequence of findings and interventions may help other physicians to manage such patients and provide a practical lesson for clinicians, especially those from developing settings. Our strengths were the close monitoring of the patient and the use of a variety of atropine concentrations. Ideally, consultation with a psychiatrist should have occurred earlier; nonetheless, we do not work in a general hospital, so it took 4 weeks for the consultation to the pediatric hospital. Another option, not available to us, would be to perform a visual evoked potential (VEP) as an objective assessment, as VEP has shown to be useful in differentiating functional from organic visual loss \[[@B5]\].

Conclusion {#sec1_4}
==========

Ophthalmologists should be aware of underlying psychological and psychiatric issues in order to refer the patient properly and to optimize care.
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